HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

3-(1-Methylpyrrolidin-2-yl)pyridine

HCID 942
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
22083-74-5
Standard SMILES
CN1CCCC1c1cccnc1
InChIKey
SNICXCGAKADSCV-UHFFFAOYSA-N
Molecular formula
C10H14N2
Average molar mass
162.23 g/mol
Monoisotopic mass
162.11569846

Overview

3-(1-methylpyrrolidin-2-yl)pyridine is an N-alkylpyrrolidine that consists of N-methylpyrrolidine bearing a pyridin-3-yl substituent at position 2. It is a pyridine alkaloid, a pyrrolidine alkaloid and a N-alkylpyrrolidine.

Names & identifiers

Preferred name
3-(1-Methylpyrrolidin-2-yl)pyridine
IUPAC
3-(1-methylpyrrolidin-2-yl)pyridine

Names & synonyms

3-(1-methylpyrrolidin-2-yl)pyridineDL-NicotineDTXSID3048154CHEBI:1380003-[1-Methylpyrrolidin-2-yl]pyridineRefChem:489602(+-)NICOTINEDTXCID9028128623-834-222083-74-5(+/-)-Nicotine(R,S)-Nicotine
Show more names
rac-Nicotine(RS)-Nicotine(+-)-Nicotine75202-10-7CHEMBL440464S-(-)-Nicotinedestruxolfumeto bac

Database identifiers

CAS
22083-74-5、54-11-5
PubChem CID
942
DTXSID
DTXSID3048154
ChEMBL
CHEMBL440464
ChEBI
CHEBI:138000
EC Number
623-834-2
Nikkaji
J23.948H

Properties

Computed structural properties

XLogP
1.2
Topological polar surface area
16.1 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
2
Rotatable bonds
1
Heavy atoms
12
Formal charge
0
Complexity
147

Experimental & physicochemical properties

DrugsPharmaceuticals

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H301 (92.7%): Toxic if swallowed [Danger Acute toxicity, oral]

P262, P264, P270, P273, P280, P301+P316, P302+P352, P316, P321, P330, P361+P364, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Hazard Classes and CategoriesAcute Tox. 3 (92.7%)

Toxicology

Treatment · 1 item

Other supportive measures include diazepam or barbiturates for seizures, atropine for excessive bronchial secretions or diarrhea, respiratory support for respiratory failure, and vigorous fluid support for hypotension and cardiovascular collapse. (L1712)

Health EffectsNicotine has mood-altering effects that may include relaxation, sharpness, calmness, and alertness. It may act as a stimulant or sedative/pain killer, depending on the dosage. (L327)
Exposure Routes · 1 item

Oral (L327) ; Inhalation (L327) Absorption of nicotine through the buccal mucosa is relatively slow and the high and rapid rise followed by the decline in nicotine arterial plasma concentrations seen with cigarette smoking are not achieved with the inhaler. About 10% of absorbed nicotine is excreted unchanged in urine.

Toxicity Summary · 1 item

Nicotine is a stimulant drug that acts as an agonist at nicotinic acetylcholine receptors. These are ionotropic receptors composed up of five homomeric or heteromeric subunits. In the brain, nicotine binds to nicotinic acetylcholine receptors on dopaminergic neurons in the cortico-limbic pathways. This causes the channel to open and allow conductance of multiple cations including sodium, calcium, and potassium. This leads to depolarization, which activates voltage-gated calcium channels and allows more calcium to enter the axon terminal. Calcium stimulates vesicle trafficking towards the plasma membrane and the release of dopamine into the synapse. Dopamine binding to its receptors is responsible the euphoric and addictive properties of nicotine. Nicotine also binds to nicotinic acetylcholine receptors on the chromaffin cells in the adrenal medulla. Binding opens the ion channel allowing influx of sodium, causing depolarization of the cell, which activates voltage-gated calcium channels. Calcium triggers the release of epinephrine from intracellular vesicles into the bloodstream, which causes vasoconstriction, increased blood pressure, increased heart rate, and increased blood sugar.

Signs and SymptomsSymptoms of overdose include nausea, abdominal pain, vomiting, diarrhea, diaphoresis, flushing, dizziness, disturbed hearing and vision, confusion, weakness, palpitations, altered respiration and hypotension.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Toxicity DataLD50: 140 mg/kg (Dermal, Rat) LD50: 25 mg/kg (Subcutaneous, Rat) LD50: 5900 ug/kg (Intraperitoneal, Mouse) LD50: 2.8 mg/kg (Intravenous, Rat) (T80) LD50: 24 mg/kg (Oral, Mouse) (T18)

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 2 items

Nicotine has known human metabolites that include Nicotine N-glucuronide.

As nicotine enters the body, it is distributed quickly through the bloodstream and can cross the blood-brain barrier. On average it takes about seven seconds for the substance to reach the brain when inhaled. The half life of nicotine in the body is around two hours. Nicotine is metabolized in the liver by cytochrome P450 enzymes (mostly CYP2A6, and also by CYP2B6). A major metabolite is cotinine. Other primary metabolites include nicotine N'-oxide, nornicotine, nicotine isomethonium ion, 2-hydroxynicotine and nicotine glucuronide. (L327) Route of Elimination: About 10% of the nicotine absorbed is excreted unchanged in the urine. Half Life: Cotinine has a half life of 15-20 hours, while nicotine has a half life of 1-3 hours

Uses & manufacturing

Uses · 1 item

Nicotine is highly toxic alkaloid found in the nightshade family of plants (Solanaceae). (L327) NICOTROL Inhaler is indicated as an aid to smoking cessation for the relief of nicotine withdrawal symptoms. NICOTROL Inhaler therapy is recommended for use as part of a comprehensive behavioral smoking cessation program. It is used for the relief of nicotine withdrawal symptoms and as an aid to smoking cessation.

Related reactions

61 records
New reaction record
HRID 11750 reaction equation
HRID 11750As reactant
HRID 15380 reaction equation
HRID 15380As reactant
HRID 31084 reaction equation
HRID 31084As reactant
HRID 44666 reaction equation
HRID 44666As reactant
HRID 55545 reaction equation
HRID 55545As reactant
HRID 59711 reaction equation
HRID 59711As product
HRID 175040 reaction equation
HRID 175040As product
HRID 218056 reaction equation
HRID 218056As reactant
PreviousPage 1 of 8

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes